AU9002798A - Fused or nonfused benzene compounds - Google Patents
Fused or nonfused benzene compoundsInfo
- Publication number
- AU9002798A AU9002798A AU90027/98A AU9002798A AU9002798A AU 9002798 A AU9002798 A AU 9002798A AU 90027/98 A AU90027/98 A AU 90027/98A AU 9002798 A AU9002798 A AU 9002798A AU 9002798 A AU9002798 A AU 9002798A
- Authority
- AU
- Australia
- Prior art keywords
- nonfused
- fused
- benzene compounds
- benzene
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25578797 | 1997-09-19 | ||
| JP9-255787 | 1997-09-19 | ||
| PCT/JP1998/004116 WO1999015520A1 (en) | 1997-09-19 | 1998-09-11 | Fused or nonfused benzene compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU9002798A true AU9002798A (en) | 1999-04-12 |
Family
ID=17283634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU90027/98A Abandoned AU9002798A (en) | 1997-09-19 | 1998-09-11 | Fused or nonfused benzene compounds |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU9002798A (en) |
| WO (1) | WO1999015520A1 (en) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EE200100556A (en) | 1999-04-28 | 2003-02-17 | Aventis Pharma Deutschland Gmbh | A diaryl acid derivative, a pharmaceutical composition containing it, and the use of the compound in the manufacture of a medicament |
| US6436993B1 (en) | 1999-07-13 | 2002-08-20 | The Salk Institute For Biological Studies | Use of RAR antagonists as modulators of hormone mediated processes |
| TW200514783A (en) | 1999-09-22 | 2005-05-01 | Bristol Myers Squibb Co | Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method |
| US6414002B1 (en) | 1999-09-22 | 2002-07-02 | Bristol-Myers Squibb Company | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| US6982251B2 (en) | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
| KR20070120617A (en) | 2001-01-26 | 2007-12-24 | 쉐링 코포레이션 | Pharmaceutical composition comprising a substituted azetidinone compound |
| EP1911462A3 (en) | 2001-01-26 | 2011-11-30 | Schering Corporation | Compositions comprising a sterol absorption inhibitor |
| ES2290562T3 (en) | 2001-01-26 | 2008-02-16 | Schering Corporation | RECEIVER ACTIVATOR COMBINATIONS ACTIVATED BY THE PEROXISOM PROLIFERATOR (PPAR) PHENOFIBRATE WITH THE INHIBITOR OF THE EZETIMIBLE STEROL ABSORPTION FOR VASCULAR INDICATIONS. |
| US7071181B2 (en) | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
| WO2002102780A1 (en) | 2001-06-18 | 2002-12-27 | Ono Pharmaceutical Co., Ltd. | Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
| US7132415B2 (en) | 2001-09-21 | 2006-11-07 | Schering Corporation | Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors |
| US7053080B2 (en) | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
| US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
| WO2004004665A2 (en) | 2002-07-09 | 2004-01-15 | Bristol-Myers Squibb Company | Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| MXPA05004810A (en) | 2002-11-06 | 2005-07-22 | Schering Corp | Cholesterol absorption inhibitors for the treatment of demyelination. |
| EP1601669B1 (en) | 2003-03-07 | 2008-12-24 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| WO2004081004A1 (en) | 2003-03-07 | 2004-09-23 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| ATE406364T1 (en) | 2003-03-07 | 2008-09-15 | Schering Corp | SUBSTITUTED AZETIDINONE DERIVATIVES, THEIR PHARMACEUTICAL FORMULATIONS AND THEIR USE IN THE TREATMENT OF HYPERCHOLESTEROLEMIA |
| WO2005097127A2 (en) | 2004-04-02 | 2005-10-20 | Merck & Co., Inc. | Method of treating men with metabolic and anthropometric disorders |
| KR20070045153A (en) | 2004-05-29 | 2007-05-02 | 7티엠 파마 에이/에스 | Medicinal RH2 Receptor Ligand |
| ITRM20050389A1 (en) | 2005-07-22 | 2007-01-23 | Giuliani Spa | COMPOUNDS AND THEIR SPECIFIC SALTS FOR PPAR RECEPTORS AND RECEPTORS FOR EGF AND THEIR USE IN MEDICAL FIELDS. |
| ITRM20050390A1 (en) * | 2005-07-22 | 2007-01-23 | Giuliani Spa | COMPOUNDS AND THEIR SPECIFIC SALTS FOR PPAR RECEPTORS AND RECEPTORS FOR EGF AND THEIR USE IN MEDICAL FIELDS. |
| UA107562C2 (en) | 2008-12-05 | 2015-01-26 | METHOD OF TREATMENT OF PSORIASIS | |
| HUE032999T2 (en) | 2009-02-16 | 2017-11-28 | Nogra Pharma Ltd | Alkylamide compounds and their use |
| US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
| BR112014019399A2 (en) | 2012-02-09 | 2017-07-04 | Nogra Pharma Ltd | fibrosis treatment methods |
| KR20150002819A (en) | 2012-04-18 | 2015-01-07 | 노그라 파마 리미티드 | Methods of treating lactose intolerance |
| EP3921299B1 (en) | 2019-02-08 | 2024-11-20 | Nogra Pharma Limited | Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4205079A (en) * | 1978-10-16 | 1980-05-27 | Shell Oil Company | Benzodioxincarboxamides |
| JPS6150977A (en) * | 1984-08-20 | 1986-03-13 | Ono Pharmaceut Co Ltd | Novel condensed benz(thio)amide, preparation thereof and pharmaceutical containing same as active constituent |
| JPS61118380A (en) * | 1984-11-14 | 1986-06-05 | Shionogi & Co Ltd | Novel 1,4-benzodioxane and 1,4-benzodioxine derivative and preparation thereof |
| IL101785A0 (en) * | 1991-05-10 | 1992-12-30 | Fujisawa Pharmaceutical Co | Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
-
1998
- 1998-09-11 WO PCT/JP1998/004116 patent/WO1999015520A1/en not_active Ceased
- 1998-09-11 AU AU90027/98A patent/AU9002798A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999015520A1 (en) | 1999-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU9002798A (en) | Fused or nonfused benzene compounds | |
| AU7210598A (en) | Novel compounds | |
| AU6804098A (en) | Triazinylaminostilbene compounds | |
| ZA985323B (en) | New compounds | |
| AU8872198A (en) | Aminometyl oxooxazolidinyl benzene derivatives | |
| GB2345910B (en) | Photochromic compounds | |
| AU9066598A (en) | Substituted 4-benzoyl-pyrazoles | |
| AU6422098A (en) | Benzene derivatives | |
| AU7476598A (en) | 18-substituted-19-nor-vitamin d compounds | |
| AUPO941497A0 (en) | Novel compounds | |
| AUPP042397A0 (en) | 5-arylpyrazole compounds | |
| AU6747498A (en) | Benzene derivatives | |
| AU7124598A (en) | Polymer-platinum compounds | |
| GB9512479D0 (en) | Substituted benzene derivatives | |
| ZA983736B (en) | New compounds | |
| AU8019998A (en) | Fluoromethoximino compounds | |
| AU6090898A (en) | Substituted 4-benzoyl-pyrazoles | |
| GB9713732D0 (en) | Substituted triazinic compounds | |
| AUPP003297A0 (en) | 4,5-diaryloxazole compounds | |
| AUPO691897A0 (en) | New compound | |
| AU1334399A (en) | Tricyclic 3-oxo-propanenitrile compounds | |
| AU7041098A (en) | Pi-complex compounds | |
| AU9753998A (en) | Azaboroxine compounds | |
| AU1878199A (en) | Photochromic compounds | |
| AU7530198A (en) | Substituted 4-benzoyl-pyrazoles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |